The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA).On Dec. 20, ...

The FDA suggests that prescribed users also reduce their calorie intake and increase their exercise The weight loss drug ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The United States Food and Drug Administration (FDA) has approved the weight-loss drug Tirzepatide — sold by the brand name ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.